The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia von Issa, Ghayas C., Aldoss, Ibrahim, DiPersio, John, Cuglievan, Branko, Stone, Richard, Arellano, Martha, Thirman, Michael J., Patel, Manish R., Dickens, David S., Shenoy, Shalini, Shukla, Neerav, Kantarjian, Hagop, Armstrong, Scott A., Perner, Florian, Perry, Jennifer A., Rosen, Galit, Bagley, Rebecca G., Meyers, Michael L., Ordentlich, Peter, Gu, Yu, Kumar, Vinit, Smith, Steven, McGeehan, Gerard M., Stein, Eytan M.

Volltext

Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer von Bardia, Aditya, Kaklamani, Virginia, Wilks, Sharon, Weise, Amy, Richards, Donald, Harb, Wael, Osborne, Cynthia, Wesolowski, Robert, Karuturi, Meghan, Conkling, Paul, Bagley, Rebecca G, Wang, Yamei, Conlan, Maureen G, Kabos, Peter

Volltext

Commentary on Folkman: "Tumor Angiogenesis Factor" von Bagley, Rebecca G

Volltext

A phase 1b study evaluating the effect of elacestrant treatment on estrogen receptor availability and estradiol binding to the estrogen receptor in metastatic breast cancer lesions... von Jager, Agnes, de Vries, Elisabeth G. E., der Houven van Oordt, C. Willemien Menke-van, Neven, Patrick, Venema, Clasina M., Glaudemans, Andor W. J. M., Wang, Yamei, Bagley, Rebecca G., Conlan, Maureen G., Aftimos, Philippe

Volltext

Differential antitumor activity of aflibercept and bevacizumab in patient-derived xenograft models of colorectal cancer von Chiron, Marielle, Bagley, Rebecca G, Pollard, Jack, Mankoo, Parminder K, Henry, Christophe, Vincent, Loïc, Geslin, Catherine, Baltes, Nina, Bergstrom, Donald A

Volltext

A First-in-Human Phase 1 Study of a Novel Selective Androgen Receptor Modulator (SARM), RAD140, in ER+/HER2- Metastatic Breast Cancer von LoRusso, Patricia, Hamilton, Erika, Ma, Cynthia, Vidula, Neelima, Bagley, Rebecca G., Troy, Steven, Annett, Miriam, Yu, Ziyang, Conlan, Maureen G., Weise, Amy

Volltext

Abstract 5032: Glycoprotein NMB (gpNMB) overexpression is prevalent in human cancers: pancreatic cancer, non-small cell lung cancer, head and neck cancer, and osteosarcoma von Halim, Abdel, Bagley, Rebecca G., Keler, Tibor

Volltext

A phase 2 study of glembatumumab vedotin, an antibody‐drug conjugate targeting glycoprotein NMB, in patients with advanced melanoma von Ott, Patrick A., Pavlick, Anna C., Johnson, Douglas B., Hart, Lowell L., Infante, Jeffrey R., Luke, Jason J., Lutzky, Jose, Rothschild, Neal E., Spitler, Lynn E., Cowey, C. Lance, Alizadeh, Aaron R., Salama, April K., He, Yi, Hawthorne, Thomas R., Bagley, Rebecca G., Zhang, Joshua, Turner, Christopher D., Hamid, Omid

Volltext

Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer (“METRIC”): a randomized multicenter study von Vahdat, Linda T., Schmid, Peter, Forero-Torres, Andres, Blackwell, Kimberly, Telli, Melinda L., Melisko, Michelle, Möbus, Volker, Cortes, Javier, Montero, Alberto J., Ma, Cynthia, Nanda, Rita, Wright, Gail S., He, Yi, Hawthorne, Thomas, Bagley, Rebecca G., Halim, Abdel-Baset, Turner, Christopher D., Yardley, Denise A.

Volltext

Placental Growth Factor Upregulation Is a Host Response to Antiangiogenic Therapy von BAGLEY, Rebecca G, YI REN, TEICHER, Beverly A, WEBER, William, MIN YAO, KURTZBERG, Leslie, PINCKNEY, Jason, BANGARI, Dinesh, NGUYEN, Cokey, BRONDYK, William, KAPLAN, Johanne

Volltext

Pericytes and endothelial precursor cells : Cellular interactions and contributions to malignancy von BAGLEY, Rebecca G, WEBER, William, ROULEAU, Cecile, TEICHER, Beverly A

Volltext

Human choriocarcinomas: Placental growth factor-dependent preclinical tumor models von BAGLEY, Rebecca G, YI REN, KURTZBERG, Leslie, WEBER, William, BANGARI, Dinesh, BRONDYK, William, TEICHER, Beverly A

Volltext

Genz-644282, a Novel Non-Camptothecin Topoisomerase I Inhibitor for Cancer Treatment von KURTZBERG, Leslie S, ROTH, Stephanie, FEI WANG, SCHMID, Steven M, LAVOIE, Edmond J, TEICHER, Beverly A, KRUMBHOLZ, Roy, CRAWFORD, Jennifer, BORMANN, Christy, DUNHAM, Sarah, MIN YAO, ROULEAU, Cecile, BAGLEY, Rebecca G, YU, Xian-Jie

Volltext

Erufosine, an alkylphosphocholine, with differential toxicity to human cancer cells and bone marrow cells von Bagley, Rebecca G., Kurtzberg, Leslie, Rouleau, Cecile, Yao, Min, Teicher, Beverly A.

Volltext

Endosialin/TEM 1/CD248 is a pericyte marker of embryonic and tumor neovascularization von Bagley, Rebecca G., Honma, Nakayuki, Weber, William, Boutin, Paula, Rouleau, Cecile, Shankara, Srinivas, Kataoka, Shiro, Ishida, Isao, Roberts, Bruce L., Teicher, Beverly A.

Volltext

Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers von BAGLEY, Rebecca G, WEBER, William, ROULEAU, Cecile, MIN YAO, HONMA, Nakayuki, KATAOKA, Shiro, ISHIDA, Isao, ROBERTS, Bruce L, TEICHER, Beverly A

Volltext

JAK2 inhibition has different therapeutic effects according to myeloproliferative neoplasm development in mice von Debeurme, Franck, Lacout, Catherine, Moratal, Claudine, Bagley, Rebecca G., Vainchenker, William, Adrian, Francisco, Villeval, Jean‐Luc

Volltext

Endosialin Protein Expression and Therapeutic Target Potential in Human Solid Tumors: Sarcoma versus Carcinoma von ROULEAU, Cecile, CURIEL, Maritza, HASEGAWA, Kazumasa, ISHIDA, Isao, KATAOKA, Shiro, THURBERG, Beth L, MEHRAEIN, Khodadad, HORTEN, Bruce, MILLER, Glenn, TEICHER, Beverly A, WEBER, William, SMALE, Robert, KURTZBERG, Leslie, MASCARELLO, James, BERGER, Carol, WALLAR, Gina, BAGLEY, Rebecca, HONMA, Nakayuki

Volltext

Characteristics of human Ewing/PNET sarcoma models von Teicher, Beverly A, Bagley, Rebecca G, Rouleau, Cecile, Kruger, Ariel, Ren, Yi, Kurtzberg, Leslie

Volltext

Human endothelial precursor cells express tumor endothelial marker 1/endosialin/CD248 von Bagley, Rebecca G, Rouleau, Cecile, St Martin, Thia, Boutin, Paula, Weber, William, Ruzek, Melanie, Honma, Nakayuki, Nacht, Mariana, Shankara, Srinivas, Kataoka, Shiro, Ishida, Isao, Roberts, Bruce L, Teicher, Beverly A

Volltext